Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Shipp

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Blood|March 1, 1994
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?M A Shipp
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Can we improve upon the International Index?M A Shipp
Blood|June 1, 1995
Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elementsF Ishimaru, M A Shipp
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1987
Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signalsM A Shipp, E L Reinherz
Current Opinion in Oncology|November 4, 1998
The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomasO M Howard, M A Shipp
Blood|August 15, 1993
Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!M A Shipp, A T Look
Seminars in Hematology|January 1, 1994
Chemotherapy of non-Hodgkin's aggressive lymphomasG Salles, M A Shipp, B Coiffier
Blood|June 1, 1997
The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoformsF Ishimaru, B Mari, M A Shipp
Journal of Neuroimmunology|February 1, 1991
A possible immunoregulatory function for [Met]-enkephalin-Arg6-Phe7 involving human and invertebrate granulocytesG B Stefano, M A Shipp, B Scharrer
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992
Opioid receptor agonists and Ca2+ modulation in human B cell linesW Heagy, M A Shipp, R W Finberg
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Blood|March 1, 1994
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?M A Shipp
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Can we improve upon the International Index?M A Shipp
Blood|June 1, 1995
Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elementsF Ishimaru, M A Shipp
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1987
Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signalsM A Shipp, E L Reinherz
Current Opinion in Oncology|November 4, 1998
The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomasO M Howard, M A Shipp
Blood|August 15, 1993
Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!M A Shipp, A T Look
Seminars in Hematology|January 1, 1994
Chemotherapy of non-Hodgkin's aggressive lymphomasG Salles, M A Shipp, B Coiffier
Blood|June 1, 1997
The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoformsF Ishimaru, B Mari, M A Shipp
Journal of Neuroimmunology|February 1, 1991
A possible immunoregulatory function for [Met]-enkephalin-Arg6-Phe7 involving human and invertebrate granulocytesG B Stefano, M A Shipp, B Scharrer
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992
Opioid receptor agonists and Ca2+ modulation in human B cell linesW Heagy, M A Shipp, R W Finberg
Pageof 6